AQR Capital Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.59M Sell
144,060
-9,353
-6% -$188K ﹤0.01% 2178
2025
Q4
$3.59M Sell
153,413
-50,778
-25% -$1.1M ﹤0.01% 1776
2025
Q3
$4.07M Sell
204,191
-27,383
-12% -$492K ﹤0.01% 1573
2025
Q2
$3.17M Buy
231,574
+117,508
+103% +$1.13M ﹤0.01% 1519
2025
Q1
$1.26M Buy
114,066
+88,577
+348% +$944K ﹤0.01% 1877
2024
Q4
$271K Sell
25,489
-92,450
-78% -$1.11M ﹤0.01% 2537
2024
Q3
$1.5M Buy
117,939
+87,649
+289% +$1.3M ﹤0.01% 1637
2024
Q2
$508K Sell
30,290
-11,972
-28% -$170K ﹤0.01% 2049
2024
Q1
$634K Buy
42,262
+23,879
+130% +$390K ﹤0.01% 1865
2023
Q4
$276K Buy
+18,383
New +$239K ﹤0.01% 2092

Other funds holding URGN